Cheng H - Search Results

1

AJCC 7th edition staging classification is more applicable than AJCC 8th edition staging classification for invasive IPMN.

Fan Z, Cheng H, Jin K, Gong Y, Huang Q, Xu J, Ni Q, Yu X, Liu C, Luo G. Fan Z, et al. Among authors: cheng h. World J Surg Oncol. 2019 Aug 6;17(1):137. doi: 10.1186/s12957-019-1682-9. World J Surg Oncol. 2019. PMID: 31387646 Free PMC article.

2

microRNA signature for human pancreatic cancer invasion and metastasis.

Cheng H, Shi S, Cai X, Long J, Xu J, Liu C, Yu X. Cheng H, et al. Exp Ther Med. 2012 Aug;4(2):181-187. doi: 10.3892/etm.2012.585. Epub 2012 May 21. Exp Ther Med. 2012. PMID: 22970025 Free PMC article.

3

Abnormal distribution of peripheral lymphocyte subsets induced by PDAC modulates overall survival.

Xu YF, Lu Y, Cheng H, Shi S, Xu J, Long J, Liu L, Liu C, Yu X. Xu YF, et al. Among authors: cheng h. Pancreatology. 2014 Jul-Aug;14(4):295-301. doi: 10.1016/j.pan.2014.05.797. Epub 2014 Jun 11. Pancreatology. 2014. PMID: 25062880

4

Stathmin destabilizing microtubule dynamics promotes malignant potential in cancer cells by epithelial-mesenchymal transition.

Lu Y, Liu C, Xu YF, Cheng H, Shi S, Wu CT, Yu XJ. Lu Y, et al. Among authors: cheng h. Hepatobiliary Pancreat Dis Int. 2014 Aug;13(4):386-94. doi: 10.1016/s1499-3872(14)60038-2. Hepatobiliary Pancreat Dis Int. 2014. PMID: 25100123 Review.

5

Epithelial-mesenchymal transition in pancreatic cancer: Is it a clinically significant factor?

Jiang JH, Liu C, Cheng H, Lu Y, Qin Y, Xu YF, Xu J, Long J, Liu L, Ni QX, Yu XJ. Jiang JH, et al. Among authors: cheng h. Biochim Biophys Acta. 2015 Jan;1855(1):43-9. doi: 10.1016/j.bbcan.2014.11.004. Epub 2014 Nov 26. Biochim Biophys Acta. 2015. PMID: 25432020 Review.

6

Pancreatic cancer: BRCA mutation and personalized treatment.

Luo G, Lu Y, Jin K, Cheng H, Guo M, Liu Z, Long J, Liu C, Ni Q, Yu X. Luo G, et al. Among authors: cheng h. Expert Rev Anticancer Ther. 2015;15(10):1223-31. doi: 10.1586/14737140.2015.1086271. Epub 2015 Sep 7. Expert Rev Anticancer Ther. 2015. PMID: 26402249 Review.

7

iPSCs Derived from Malignant Tumor Cells: Potential Application for Cancer Research.

Cheng H, Liu C, Cai X, Lu Y, Xu Y, Yu X. Cheng H, et al. Curr Stem Cell Res Ther. 2016;11(5):444-50. doi: 10.2174/1574888x11666160217154748. Curr Stem Cell Res Ther. 2016. PMID: 26899393 Review.

8

Which patients with para-aortic lymph node (LN16) metastasis will truly benefit from curative pancreaticoduodenectomy for pancreatic head cancer?

Liu C, Lu Y, Luo G, Cheng H, Guo M, Liu Z, Xu J, Long J, Liu L, Fu D, Ni Q, Li M, Yu X. Liu C, et al. Among authors: cheng h. Oncotarget. 2016 May 17;7(20):29177-86. doi: 10.18632/oncotarget.8690. Oncotarget. 2016. PMID: 27081079 Free PMC article.

9

The Prognostic and Predictive Role of Epidermal Growth Factor Receptor in Surgical Resected Pancreatic Cancer.

Guo M, Luo G, Liu C, Cheng H, Lu Y, Jin K, Liu Z, Long J, Liu L, Xu J, Huang D, Ni Q, Yu X. Guo M, et al. Among authors: cheng h. Int J Mol Sci. 2016 Jul 8;17(7):1090. doi: 10.3390/ijms17071090. Int J Mol Sci. 2016. PMID: 27399694 Free PMC article.

10

The combination of systemic inflammation-based marker NLR and circulating regulatory T cells predicts the prognosis of resectable pancreatic cancer patients.

Cheng H, Luo G, Lu Y, Jin K, Guo M, Xu J, Long J, Liu L, Yu X, Liu C. Cheng H, et al. Pancreatology. 2016 Nov-Dec;16(6):1080-1084. doi: 10.1016/j.pan.2016.09.007. Epub 2016 Sep 16. Pancreatology. 2016. PMID: 27665172

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,936 results

Search Page

Filters